News & Media

Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development

Press Releases · August 10, 2022

Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development

Six Trends Shaping the Future of Health Care

News · March 1, 2019

Six Trends Shaping the Future of Health Care

Health startups poised to make a splash in 2018

News · January 18, 2018

Health startups poised to make a splash in 2018